Traduction de «Drogue primaire » (Français → Anglais) :

Definition: This block contains a wide variety of disorders that differ in severity and clinical form but that are all attributable to the use of one or more psychoactive substances, which may or may not have been medically prescribed. The third character of the code identifies the substance involved, and the fourth character specifies the clinical state. The codes should be used, as required, for each substance specified, but it should be noted that not all fourth character codes are applicable to all substances. Identification of the psychoactive substance should be based on as many sources of information as possible. These include self-report data, analysis of blood and other body fluids, characteristic physical and psychological symptom ...[+++]s, clinical signs and behaviour, and other evidence such as a drug being in the patient's possession or reports from informed third parties. Many drug users take more than one type of psychoactive substance. The main diagnosis should be classified, whenever possible, according to the substance or class of substances that has caused or contributed most to the presenting clinical syndrome. Other diagnoses should be coded when other psychoactive substances have been taken in intoxicating amounts (common fourth character .0) or to the extent of causing harm (common fourth character .1), dependence (common fourth character .2) or other disorders (common fourth character .3-.9). Only in cases in which patterns of psychoactive substance-taking are chaotic and indiscriminate, or in which the contributions of different psychoactive substances are inextricably mixed, should the diagnosis of disorders resulting from multiple drug use (F19.-) be used. | Modifiers The following fourth-character subdivisions are for use with categories F10-F19: Code Title .0 Acute intoxication A condition that follows the administration of a psychoactive substance resulting in disturbances in level of consciousness, cognition, perception, affect or behaviour, o ...

An Act to amend the Food and Drugs Act and the Narcotic Control Act (trafficking in a controlled or a restricted drug or narcotic within five hundred meters of an elementary school of high school)

An Act to amend the Controlled Drugs and Substances Act (trafficking in a controlled drug or substance within five hundred metres of an elementary school or a high school)

first-time hard-drug user

addictive drug | dependence-producing drug | habit-forming drug

detect abuse of drugs | detected drug abuse | detect drug abuse | identify substance dependence

Definition: This category should be used when two or more psychoactive substances are known to be involved, but it is impossible to assess which substance is contributing most to the disorders. It should also be used when the exact identity of some or even all the psychoactive substances being used is uncertain or unknown, since many multiple drug users themselves often do not know the details of what they are taking. | misuse of drugs NOS

Definition: The schizophrenic disorders are characterized in general by fundamental and characteristic distortions of thinking and perception, and affects that are inappropriate or blunted. Clear consciousness and intellectual capacity are usually maintained although certain cognitive deficits may evolve in the course of time. The most important psychopathological phenomena include thought echo; thought insertion or withdrawal; thought broadcasting; delusional perception and delusions of control; influence or passivity; hallucinatory voices commenting or discussing the patient in the third person; thought disorders and negative symptoms. The course of schizophrenic disorders can be either continuous, or episodic with progressive or st ...[+++]able deficit, or there can be one or more episodes with complete or incomplete remission. The diagnosis of schizophrenia should not be made in the presence of extensive depressive or manic symptoms unless it is clear that schizophrenic symptoms antedate the affective disturbance. Nor should schizophrenia be diagnosed in the presence of overt brain disease or during states of drug intoxication or withdrawal. Similar disorders developing in the presence of epilepsy or other brain disease should be classified under F06.2, and those induced by psychoactive substances under F10-F19 with common fourth character .5.

elementary school supply teacher [ elementary school substitute teacher ]

My bill proposes to amend the Controlled Drugs and Substances Act to impose a minimum prison term of one year for the first offence and two years for further offences in cases where a person is convicted of trafficking in a controlled or restricted drug or narcotic within five hundred metres of an elementary school or a high school.

The Prevention Action Plan refocuses existing community-based, drug-use prevention strategies, programs and services for youth; provides information directly to parents, educators, and health professionals; develops materials for school-based awareness and prevention strategies for elementary and secondary school students; discourages illicit drug use through new, national public awareness campaigns and provides financial assistance to communities for local projects to tackle the growing challenges of illicit drug use among young people.

F. whereas the Council negotiated within the Horizontal Drugs Group and the CATS (the committee referred to in Article 36 of the EU Treaty) the contents of the draft EU Drugs Strategy (2005-2012), without knowing the political and technical assessments of either the EU Drugs Strategy (2000-2004) or the implementation of the EU Action Plan on Drugs (2000-2004) drawn up by the Commission and the EMCDDA, the results of which were submitted to the JHA Council on 25-26 October 2004 by the Commission and to Parliament on 24 November 2004 by the EMCDDA to enable an assessment to be made of the extent to which the eleven general objectives and ...[+++]the six principal objectives established as part of the EU Drugs Strategy (2000-2004) have been achieved,

take account of the fact that the assessments made to date of the six main objectives set by the EU Drugs Strategy (2000-2004) show that none of them achieved favourable results and draw political and legislative lessons from this when devising the EUDrugs Strategy (2005-2012) and the related action plans;